Exelixis Inc (EXEL)
33.29
-0.39
(-1.16%)
USD |
NASDAQ |
Dec 20, 16:00
33.29
0.00 (0.00%)
After-Hours: 20:00
Exelixis Total Liabilities (Quarterly): 684.86M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co Inc | 72.97B |
| ADMA Biologics Inc | 158.73M |
| Alnylam Pharmaceuticals Inc | 4.173B |
| Pfizer Inc | 126.92B |
| Sarepta Therapeutics Inc | 2.379B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.960B |
| Shareholders Equity (Quarterly) | 2.275B |
| Current Ratio | 3.930 |